Method for determining the severity and prognosis of rsv infection Universiteit Antwerpen
Peter Delputte, Annemieke Smet, Stijn Verhulst, Benedicte De Winter, Winke Van der Gucht, Kim Stobbelaar
The present invention provides an in vitro method for determining the severity and/or prognosis of a respiratory syncytial virus (RSV) infection in a subject, based on the expression of one or more mucin genes in respiratory epithelial cells. The respiratory epithelial cells can be isolated from a biological sample of a subject, or they can be cultured in vitro and exposed to a biological sample of the subject.